Affymax

Affymax PEG

PEG Ratio (Price/Earnings-to-Growth) of Affymax (AFFY) as of Oct 9, 2026.

PEG

-0.00

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Affymax is 2013 -0.00 . PEG Ratio (Price/Earnings-to-Growth) of Affymax was 2012 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Affymax since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Affymax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Affymax

All Key Metrics — Affymax